Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarey Drugs & Pharmaceuticals has informed the stock exchanges that the trading window for its securities will be closed starting April 1, 2026. The closure applies to insiders, designated persons, and their immediate relatives, and will remain in effect until 48 hours after the company announces its audited financial results for the fourth quarter and full financial year ending March 31, 2026. This is a routine compliance measure under SEBI's Insider Trading Regulations to prevent trading on unpublished price-sensitive information. The date of the board meeting to approve the annual results will be communicated separately.
This is a standard regulatory filing and not a material business event. It signals that audited FY26 results are approaching, which investors should watch for, but it has no direct impact on the stock price or shareholder value.